lobbying_activities: 3048469

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3048469	fa3d9820-cada-4428-bd69-3b09779a5cb2	Q3	KOUNTOUPES DENHAM CARR & REID, LLC	320918	CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)	2023	third_quarter	PHA	Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles, including H.R. 405, the Essential Medicines Strategic Stockpile Act of 2023. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2023-10-12T16:34:48-04:00